1 - 15 of 312 Results Clear All
The Atlantic—The next generation of COVID vaccines may be directed against just one lineage of the Omicron strain. Melanie Ott, director of the Gladstone Institute of Virology, explains why that could be a smart strategy to elicit a strong immune response.
Gladstone Experts COVID-19 Virology Ott Lab
San Francisco Chronicle—Gladstone Senior Investigator Nadia Roan explains that while prior vaccination or exposure to COVID-19 may confer long-term protection against serious disease, a booster shot with the bivalent vaccine will protect you for a few months against new infection.
Gladstone Experts COVID-19 Virology Roan Lab
New York Times—A group of studies comparing the human genome to that of 239 other mammalian species has cast light on what makes humans unique. In particular, work from Katie Pollard, director of the Gladstone Institute of Data Science and Biotechnology, shows that changes to the way DNA folds may have been a part of what allowed humans to evolve large, powerful brains.
Gladstone Experts Data Science and Biotechnology Pollard Lab Genomics Human Genetics
Popular Science—A new study from Katie Pollard, director of the Gladstone Institute of Data Science and Biotechnology, indicates that chance structural changes in the human genome were what allowed humans to evolve the larger brains that set us apart from our primate ancestors.
Gladstone Experts Data Science and Biotechnology Pollard Lab Genomics Human Genetics
Innovative Genomics Institute—Work from Alex Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, and Affiliate Investigator Justin Eyquem demonstrates a new, more efficient and gentle method to introduce CRISPR editing machinery into cells.
Gladstone Experts Genomic Immunology Eyquem Lab Marson Lab CRISPR/Gene Editing
PBS News—Nobel Prize Laureate and Gladstone Senior Investigator Jennifer Doudna reflects on the responsible use of CRISPR, the genome editing tool she co-discovered.
Gladstone Experts Data Science and Biotechnology Doudna Lab CRISPR/Gene Editing
Colleagues look back on Warner Greene's 40 year career
Gladstone Experts History HIV/AIDS Virology Greene Lab
National Institutes of Health—Senior Investigator Katie Pollard, PhD, is featured for her work on genome organization during heart development and talks about her career path in a recent highlight of the National Institutes of Health's 4D Nucleome program.
Gladstone Experts Data Science and Biotechnology Pollard Lab Genomics
The Wall Street Journal—Induced pluripotent stem cells have the potential to be used in innovative therapies for conditions like for Parkinson’s disease, macular degeneration, and heart failure. Gladstone Senior Investigator Shinya Yamanaka, who was the first to develop the technology, describes how a patient’s own cells can be used to generate tissue for transplantation.
Gladstone Experts Yamanaka Lab Stem Cells/iPSCs
Gladstone scientists make headway toward new treatments for people with chronic long-term effects
Gladstone Experts Traumatic Brain Injury Neurological Disease Akassoglou Lab Paz Lab Srivastava Lab
Science is Fun Podcast—Assistant Investigator Seth Shipman describes his remarkable technological advance repurposing CRISPR gene editing technology to record information inside living cells.
Gladstone Experts Data Science and Biotechnology Shipman Lab CRISPR/Gene Editing
Nature—Alex Marson, MD, PhD, director of the Gladstone-UCSF Institute of Genomic Immunology, and his colleagues have been using CRISPR to increase the therapeutic potential of T cells. This work is part of a worldwide effort to improve the design and manufacturing of cancer-killing ‟CAR-T” cells reviewed in the journal Nature.
Gladstone Experts Cancer Genomic Immunology Marson Lab CRISPR/Gene Editing
Improvements in the cell analysis technique known as flow cytometry are helping Gladstone researchers make discoveries in immunology, stem cell biology, cardiology, and neuroscience
Gladstone Experts Flow Cytometry Core Neurological Disease Alexanian Lab Roan Lab
Gladstone scientists answer questions about the convergence of COVID-19, RSV, and the flu this winter
Gladstone Experts COVID-19 Virology Greene Lab Ott Lab Roan Lab
San Francisco Chronicle—New SARS-CoV-2 subvariants are driving an increase in COVID case numbers around the world. Gladstone Investigator Nadia Roan explains that the subvariants have mutations that help them evade neutralizing antibodies, but stresses that getting the bivalent vaccine can still help strengthen immunity to the ever-changing virus.
Gladstone Experts COVID-19 Virology Roan Lab
